Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Cipro · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Ciprofloxacin Extended-Release Tablets 500 mg |
| 2 | ACTIVE_COMPARATOR | Cipro® XR Tablets 500 mg |
| Name | Type | Description |
|---|---|---|
| Ciprofloxacin Extended-Release Tablets 500 mg | DRUG | 500mg, single dose fasting |
| Cipro® XR Tablets (500 mg | DRUG | 500mg, single dose fasting |
| Ciprofloxacin Extended-Release Tablets 1000 mg | DRUG | 1000mg, single dose fasting |
| Cipro® XR Tablets 1000 mg | DRUG | 1000mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (β-HCG) pregnancy tests performed within 14 days prior to the start of the study and on the eveni...
Cipro is a small molecule drug being developed by Viatris Inc. for use in healthy volunteers. It is currently in Phase 1 clinical development, with studies evaluating ciprofloxacin extended-release tablets. The drug is investigational and has not been approved for any indication.
Cipro is developed by Viatris Inc., a pharmaceutical company traded on the NASDAQ under the ticker symbol VTRS. The company is conducting Phase 1 clinical trials to evaluate the drug's pharmacokinetics in healthy volunteers.
Cipro is in Phase 1 clinical development. It is an investigational drug and has not been approved by regulatory authorities. All three completed trials were Phase 1 studies conducted in healthy volunteers in the United States.
Cipro has three completed Phase 1 clinical trials: NCT00649155, NCT00649662, and NCT00650351. These studies evaluated ciprofloxacin extended-release tablets at doses of 500 mg and 1000 mg, comparing them to Cipro XR tablets under fasting and fed conditions in healthy volunteers.
Cipro is a brand name for ciprofloxacin, a fluoroquinolone antibiotic. The clinical trials listed compare ciprofloxacin extended-release tablets to Cipro XR tablets, indicating that Cipro refers to the reference product. The drug is being studied in healthy volunteers.